| Line 5: | Line 5: | ||
<br> | <br> | ||
'''<big>Are alternative nicotine products safer than smoking? Can switching to alternative products improve oral health?</big>''' | '''<big>Are alternative nicotine products safer than smoking? Can switching to alternative products improve oral health?</big>''' | ||
=ENDS NVP E-Cigarettes= | =ENDS NVP ANDS E-Cigarettes= | ||
===2023: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226679/ The risk profile of electronic nicotine delivery systems, compared to traditional cigarettes, on oral disease: a review]=== | ===2023: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226679/ The risk profile of electronic nicotine delivery systems, compared to traditional cigarettes, on oral disease: a review]=== | ||
| Line 14: | Line 14: | ||
===2022: [https://www.cdhjournal.org/issues/39-2-june-2022/1124-electronic-cigarettes-an-update-on-products-regulation-public-health-approaches-and-oral-health Electronic cigarettes: an update on products, regulation, public health approaches and oral health]=== | ===2022: [https://www.cdhjournal.org/issues/39-2-june-2022/1124-electronic-cigarettes-an-update-on-products-regulation-public-health-approaches-and-oral-health Electronic cigarettes: an update on products, regulation, public health approaches and oral health]=== | ||
*Regulatory approaches vary considerably around the world but in the UK and Europe, e-cigarettes are regulated as consumer or medicinal product, and their use is permitted. In the UK, e-cigarettes have increasingly been supported by public health institutions for smoking cessation as part of a Tobacco Harm Reduction strategy. | *Regulatory approaches vary considerably around the world but in the UK and Europe, e-cigarettes are regulated as consumer or medicinal product, and their use is permitted. In the UK, e-cigarettes have increasingly been supported by public health institutions for smoking cessation as part of a Tobacco Harm Reduction strategy. | ||
*The potential harms (including to oral health) from e-cigarette use are likely to be much less than from tobacco cigarettes. | *The potential harms (including to oral health) from e-cigarette use are likely to be much less than from tobacco cigarettes. | ||
===2019: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888580/ Influence of Electronic Cigarettes on Selected Antibacterial Properties of Saliva]=== | |||
*Lowering the level of IgA in saliva may lead to a weakening of the specific immune response and cause earlier development of more severe periodontitis. In our research, it was observed that the tobacco smokers’ level of salivary IgA was statistically significantly lower in comparison to the values in both the control group and the group of e-cigarette users. IgA content in the saliva of e-cigarette users was not statistically significant lower compared to the control group. This indicates that electronic cigarettes compared to traditional cigarettes have less effect on IgA concentration in saliva. | |||
===2019: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949915/ A Comparison of Flavorless Electronic Cigarette-Generated Aerosol and Conventional Cigarette Smoke on the Planktonic Growth of Common Oral Commensal Streptococci]=== | ===2019: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949915/ A Comparison of Flavorless Electronic Cigarette-Generated Aerosol and Conventional Cigarette Smoke on the Planktonic Growth of Common Oral Commensal Streptococci]=== | ||
edits